News Archives - Page 56 of 89

TuesdayFeb 14, 2023 12:52 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q4 and FY 2022 Financial Results, Earnings Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that it will provide a business update and release its financial results for the fourth quarter and full year 2022 following the close of the market on Tuesday, March 14, 2023. Cepton will host a conference call and webcast at 2:30 p.m. PT (5:30 p.m. ET) that same day. Interested parties may join the call by dialing 1-877-300-8521 (toll-free) or 1-412-317-6026 (international) and visiting Cepton’s Investor Relations page to access the live webcast. A telephonic replay will be available approximately two hours after the live…

TuesdayFeb 14, 2023 11:51 am

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms US-Based Subsidiary with Focus to Expand Innovation Platforms

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the formation of a U.S.-based wholly owned subsidiary, Pearsanta Inc. The move intends to accelerate the expansion of Aditxt’s second program, AditxtScore(TM), through future strategic revenue and growth-oriented transactions. According to the update, Anthony Voorhies, currently the head of the AditxtScore(TM) division, will serve as president of Pearsanta. Voorhies has over 20 years of clinical diagnostics and healthtech industry experience and, under his leadership, the AditxtScore(TM) division has successfully grown from inception to commercialization and revenues in just…

TuesdayFeb 14, 2023 11:28 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Q3 Financial Report, Corporate Highlights

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is reporting on its third quarter performance as well as recent business highlights; the report is for the period ended Dec. 31, 2022. In the report, the company noted that it had received approval from an independent ethics committee in the Netherlands to begin the first-in-human dosing of its CYB004 through a protocol amendment to its ongoing phase 1 CYB004-E trial; CYB004 is the company’s proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule. The company is also making progress on its phase 1/2a clinical trial evaluating CYB003 for the potential treatment…

MondayFeb 13, 2023 12:19 pm

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Completes Acquisition of the Bahia Project

Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced completion of its acquisition of 17 mineral concessions between the towns of Prado and Caravelas in the state of Bahia, Brazil, totaling 15,089.71 hectares (approximately 37,300 acres or 58.3 square miles). According to the announcement, closing of the “Bahia Project” followed the Brazilian Government’s approval of the transfers to Energy Fuels’ wholly owned Brazilian subsidiary Energy Fuels Brazil, Ltda. At the closing, Energy Fuels paid the mineral owners the remaining $21.9 million cash. “Energy Fuels has achieved yet another important milestone for our expanding rare earth business through our acquisition of…

WednesdayFeb 08, 2023 2:16 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Reports on Final Results of Jetty Simulation Study

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon-reduced solutions for the commercial, industrial and transportation sector, has concluded a detailed marine simulation study; the study will be used for the proposed design and future operations of jetty and quay wall infrastructure that will serve VENG’s Green Energy Hub in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Evolution Terminals BV, a wholly owned subsidiary of Vision Energy, contracted with Maritime Research Institute Netherlands (“MARIN”) to carry out the study, which was conducted in cooperation with North Sea Port authority. MARIN is an internationally operating, leading independent…

TuesdayFeb 07, 2023 11:57 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Spain in Key Global Trial Studying Berubicin for Treatment of GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that enrollment is continuing in its ongoing global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”). Specifically, the company is reporting that it has enrolled the first patient in Spain. As part of the trial, the company has opened 37 of 59 planned clinical trial sites; the sites are located in the United States, Italy, France, Spain and Switzerland. The company noted that it plans an interim analysis of the study when…

MondayFeb 06, 2023 3:44 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight in Vegas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced that its Robot Roadshow will land at Silverton Hotel & Casino in Las Vegas, Nevada, from 10:00 a.m. to 2:00 p.m. PT on Feb. 7-9, 2023. The engaging experiential event is designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Las Vegas Roadshow landing will be guided by Knightscope experts, and visitors will be able to interact directly with each of the ASRs and see the Knightscope Security Operations Center (‘KSOC’) user interface in action.…

MondayFeb 06, 2023 10:43 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Wins Largest Commercial Lidar Deployment Contract in Tolling Sector to Date

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been awarded a multimillion sales contract from one of the leading U.S. highway tolling systems in the country. The company announced that its exclusive, state-of-the-art lidar solution will be deployed nationwide; the contract is designed to improve and enable accurate and intelligent tolling applications. According to the announcement, the large-scale contract calls for CPTN’s Sora series lidar sensors to be positioned on several major tollways located in the Tri-State area and Northern California in what is projected to be the largest commercial lidar deployment in the tolling…

ThursdayFeb 02, 2023 1:57 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Loop Global, Menzies Aviation on LAX Pilot Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is collaborating with Menzies Aviation and Loop Global Inc. on a pilot program at the Los Angeles International Airport; the program involves Mullen’s Class 1 EV cargo vans. The world’s largest aviation services company, Menzies operates in 250-plus airports in 58 countries, providing ground, air cargo and fuel services to commercial airports and airlines. Menzies is piloting Mullen Automotive electric vans and Loop Global charging infrastructure across its operations at LAX; the program is part of Menzies commitment to identify innovative solutions as it works to become carbon neutral by…

WednesdayFeb 01, 2023 11:14 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Approval for First-in-Human Dosing of Proprietary DMT Molecule

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received key approval to initiate human dosing of CYB004, its proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule, through a protocol amendment to its ongoing CYB004-E phase 1 trial. The approval came from an independent ethics committee in the Netherlands. The first-ever trial that evaluates deuterated DMT in humans, the study is being conducted at the Centre for Human Drug Research in the Netherlands; it is the largest-ever Phase 1 DMT trial conducted to date. Based on previous studies, CYB004 has shown potential to deliver an improved bioavailability…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News